Literature DB >> 25102322

The influence of small for gestational age status on outpatient bronchopulmonary dysplasia outcomes.

J Johnson1, T Ryan2, A D Aherrera2, S A McGrath-Morrow2, J M Collaco2.   

Abstract

OBJECTIVE: To describe the characteristics of small for gestational age (SGA) and non-SGA infants with bronchopulmonary dysplasia (BPD) and to ascertain whether respiratory outcomes and health-care utilization patterns in these two populations differ. STUDY
DESIGN: Three hundred and twenty-five infants with BPD born at <32 weeks gestation were recruited in the outpatient setting. Sociodemographic data and indicators of respiratory morbidity were collected via questionnaire and retrospective chart review. RESULT: SGA infants were on average 1 month older than non-SGA infants at discharge from the neonatal intensive care unit and were more likely to have a weight less than 10th percentile at first clinic visit. History of SGA was associated with increased risk of emergency department visits as well as with caregiver perception of poor weight gain.
CONCLUSION: SGA status in infants with BPD is associated with increased health-care utilization, including length of initial hospitalization and emergency department visits.

Entities:  

Mesh:

Year:  2014        PMID: 25102322      PMCID: PMC5292823          DOI: 10.1038/jp.2014.142

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  20 in total

1.  Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network.

Authors:  I M Bernstein; J D Horbar; G J Badger; A Ohlsson; A Golan
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

2.  Compromised respiratory function in postnatal lambs after placental insufficiency and intrauterine growth restriction.

Authors:  B J Joyce; S Louey; M G Davey; M L Cock; S B Hooper; R Harding
Journal:  Pediatr Res       Date:  2001-11       Impact factor: 3.756

3.  Bronchopulmonary dysplasia in very low birth weight infants is associated with prolonged hospital stay.

Authors:  G Klinger; L Sirota; A Lusky; B Reichman
Journal:  J Perinatol       Date:  2006-08-10       Impact factor: 2.521

4.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

6.  Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at <32 weeks' gestation.

Authors:  M A Padula; T R Grover; B Brozanski; I Zaniletti; L D Nelin; J M Asselin; D J Durand; B L Short; E K Pallotto; F D Dykes; K M Reber; J R Evans; K Murthy
Journal:  J Perinatol       Date:  2013-07-04       Impact factor: 2.521

7.  Chronic oxygen dependency in infants born at less than 32 weeks' gestation: incidence and risk factors.

Authors:  L Egreteau; J Y Pauchard; D S Semama; J Matis; A Liska; B Romeo; F Cneude; I Hamon; P Truffert
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

8.  Risk factors for respiratory morbidity in infancy after very premature birth.

Authors:  A Greenough; E Limb; L Marston; N Marlow; S Calvert; J Peacock
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-05       Impact factor: 5.747

9.  Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study.

Authors:  Mithilesh K Lal; Bradley N Manktelow; Elizabeth S Draper; David J Field
Journal:  Pediatrics       Date:  2003-03       Impact factor: 7.124

10.  Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation.

Authors:  Carl Bose; Linda J Van Marter; Matthew Laughon; T Michael O'Shea; Elizabeth N Allred; Padmani Karna; Richard A Ehrenkranz; Kim Boggess; Alan Leviton
Journal:  Pediatrics       Date:  2009-08-17       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.